![Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma]()
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for GlioblastomaZahonero, C.; Aguilera, P.; Ramirez-Castillejo, C.; Pajares, M.; Bolos, M. V.; Cantero, D.; Perez-Nunez, A.; Hernandez-Lain, A.; Sanchez-Gomez, P.; Sepulveda, J. M. · Molecular Cancer Therapeutics · 2015